Covid-19 associated Pediatric Multisystem Inflammatory syndrome (PMIS): A multicentric observational clinical study from Delhi

Dr Dhiren Gupta0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1. Fever > 38â??C for >=24 hours in last 7 days
•2. Evidence of clinically severe hospitalized illness among children aged <18 years with multisystem (>=2) organ involvement
•(cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological) see table for definitions used for organ involvement.
•3. Elevated markers of inflammation (eg, neutrophilia; lymphopenia; hypoalbuminemia; and elevated levels of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6)]
•4. No other obvious microbial cause of inflammation, including bacterial sepsis and staphylococcal/streptococcal toxic shock syndromes
•5. Evidence of SARS-CoV-2 infection (Any of the following):
•5.1. Positive SARS-CoV-2 RT-PCR
•5.2. Positive serology
•5.3. Positive antigen test
•5.4. Negative for SARS-CoV-2 RT-PCR and antibody tests but with identified COVID-19 exposure within the four weeks prior to the onset of symptoms

•1. Hospital stay < 24 hours
•2. Presence of other obvious microbiological cause of inflammation/ clinical condition

发起方

Dr Dhiren Gupta